Elevated mercury levels linked with higher prevalence of non-melanoma skin cancer

Higher levels of mercury in the blood were linked with a higher prevalence of non-melanoma skin cancer, the most common human malignancy, in a study published in the British Journal of Dermatology.

For the study, researchers analyzed 2003-2016 data on 29,413 participants in the National Health and Nutrition Examination Survey. The team examined blood levels of different forms of mercury: total mercury, inorganic mercury, and methyl mercury. Compared with individuals with low total mercury, those with high total mercury had nearly double the odds of being diagnosed with non-melanoma skin cancer. Similarly, participants with high methyl mercury had a 1.7-times greater odds of non-melanoma skin cancer compared with those with low methyl mercury. Inorganic mercury levels were non-significantly but positively associated with non-melanoma skin cancer.

Most individuals in the United States are exposed to mercury through consumption of contaminated fish and shellfish.

 

Source:
Journal reference:

Rhee, J., et al. (2020) Association of blood mercury levels with nonmelanoma skin cancer in the U.S.A. using National Health and Nutrition Examination Survey data (2003–2016). British Journal of Dermatology. doi.org/10.1111/bjd.18797.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapeutic target overcomes ovarian cancer immunotherapy resistance